Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer

NCT02954536 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Gastric Cancer

Interventions

DRUG: pembrolizumab
DRUG: trastuzumab
DRUG: capecitabine
DRUG: cisplatin
DRUG: Oxaliplatin
DRUG: 5-Fluorouracil

Sponsor

Memorial Sloan Kettering Cancer Center